Multaq and Liver Damage Information
Multaq and Liver Damage : In addition, these people are at risk for reactivation of the virus—return of HBeAg positivity. This occurs approximately 20 to 30 percent of the time. An individual’s likelihood of reactivation increases if their immune system becomes suppressed. Such an occurrence may happen during treatment with immunosuppressive drugs, such as steroids (prednisone, for example), or during a severe illness, such as AIDS or cancer. Inactive carriers can also have flares of hepatitis. This may occur with or without the return of HBeAg and is noted by elevations in liver enzymes to approximately five to ten times the upper limit of normal. Repeated flares may lead to disease progression, liver scarring, and even liver failure.
More information on Multaq and Liver Damage
Acute flares of hepatitis B should be distinguished from additional infection with hepatitis A, C, or D. Infection with an additional hepatitis virus is known as superinfection. It has been estimated that approximately 20 to 30 percent of such flares are due to superinfection with another hepatitis virus. Superinfection is associated with an increased risk of liver failure.
Information from other sources on Multaq and Liver Damage
Chronic Hepatitis B
The second type of chronic hepatitis B is termed chronic hepatitis B and is found in a person who, in addition to carrying the HBsAg, also carries HBV DNA. The presence of detectable levels of HBV DNA indicates that a person is highly contagious or infectious to others. People with chronic hepatitis B may be either positive or negative for HBeAg. In both HBeAg positive and HBeAg negative people, liver enzymes are either persistently or intermittently elevated, and liver biopsy results typically reveal inflammation and damage. People with chronic hepatitis are likely to have a progressive disease leading to cirrhosis.
Our use of the term or terms Multaq and Liver Damage is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Multaq and Liver Damage visit our site often.
http://www.seedol.com